KELIX bio Enters Into a Binding Commitment to Acquire PHI, a Leading Pharmaceutical Manufacturer in Morocco

KELIX bio Enters Into a Binding Commitment to Acquire PHI, a Leading Pharmaceutical Manufacturer in Morocco

DUBAI, United Arab Emirates & RABAT, Morocco–(BUSINESS WIRE/AETOSWire)– KELIX bio, a unique pan-African biopharmaceutical platform, today announced it has entered into a binding commitment to acquire Pharmaceutical Institute (“PHI”), a leading pharmaceutical company established in Rabat. This investment marks the first entry of KELIX bio into Morocco – an important market in the company’s strategy – at a juncture where the Kingdom accelerates the successful rollout of AMO (Assurance Maladie Obligatoire), a far-reaching plan to provide universal health coverage to Moroccans. PHI was established in 1989 by the Sedrati family and is a…